Nexscient, Inc.
Company Information
Industry
Services-Prepackaged Software
SIC Code
7372
Entity Type
operating
SEC Category
Emerging growth company
State of Incorporation
DE
Business Address
2029 CENTURY PARK EAST, LOS ANGELES, CA, 90067
Mailing Address
2029 CENTURY PARK EAST, LOS ANGELES, CA, 90067
Phone
(310) 494-6620
Fiscal Year End
0630
EIN
922915192
Financial Overview
FY2025
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 8-K Current report of material events | April 1, 2026 | View on SEC |
| 10-Q Quarterly financial report | January 27, 2026 | View on SEC |
| 8-K Current report of material events | January 14, 2026 | View on SEC |
| 10-Q Quarterly financial report | November 13, 2025 | View on SEC |
| 8-K Current report of material events | November 10, 2025 | View on SEC |
| 8-K Current report of material events | November 5, 2025 | View on SEC |
| 10-K Annual financial report | September 30, 2025 | View on SEC |
| 8-K Current report of material events | August 6, 2025 | View on SEC |
| 10-Q Quarterly financial report | May 15, 2025 | View on SEC |
Annual Reports
10-K
September 30, 2025
- Added 3 major pharma clients, 2 drugs entered final testing
- AI spotted a drug side effect humans missed
Material Events
8-K
Acquisition
April 1, 2026
High Impact
- Strategic acquisition of Flipside AI to pivot into a full-service AI firm.
- Integration of Flipside's 500+ data annotators to scale AI training capabilities.
Related Companies
Companies in the same industry (SIC: 7372)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.